Phytochemical Name : Crassin (C4)

Properties Information
PhytoCAT-ID PhytoCAT-2001
Phytochemical name or plant extracts Crassin (C4)
PMID 29134467
Literature evidence Diterpenoid natural compound C4 (Crassin) exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen species.
IUPAC name (4E,8E)-2,10-dihydroxy-4,8,12-trimethyl-16-methylidene-14-oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one
Phytochemicals’ class or type of plant extracts Diterpenoid
Source of phytochemicals or plant Extracts Croton crassifolius
Geographical availability China Southeast, Hainan, Laos, Myanmar, Thailand, Vietnam
Plant parts Root
Other cancers Breast cancer
Target gene or protein pAKT, pERK
Gene or Protein evidence This decrease coincided with an unexpected increase in the expression of the cell survival effectors pAkt and pERK. In addition, we found that both the decreased cell viability and the increased pAkt/pERK levels could be rescued by the antioxidant NAC, suggesting a central role for reactive oxygen species (ROS) in the mechanism of action of C4.
Target pathways NA
IC50 At 24h and 48h: 9.16 μM and 4.65 μM against MDA-MB-231
Potency From our in vitro data we conclude that C4 exerts cytostatic effects on triple-negative breast cancer cells via a pathway involving reactive oxygen species. Its potential value in combination with cytotoxic therapies merits deeper investigation in pre-clinical models.
Cell line/ mice model MDA-MB-231
Additional information  Necrosis, apoptosis, necroptosis and ferroptosis could be ruled out as cell death mechanisms. Instead, we found that C4 induced cytostasis downstream of ROS activation. Finally, we observed a synergistic effect between C4 and the chemotherapeutic drug doxorubicin in TNBC cells.
PubChem ID 5357909
Additional PMIDs 28150949
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:342364-1
Safety NA